One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion

Purpose: To report the 12-month efficacy and safety outcomes of intravitreal ziv-aflibercept in macular edema secondary to central retinal vein occlusion (CRVO). Methods: Interventional case series documenting 12-month outcomes of intravitreal ziv-aflibercept (1.25 mg in 0.05 mL) in 6 patients with...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Mohab Eldeeb, Errol W. Chan, Chintan J. Dedhia, Ahmad Mansour, Jay Chhablani
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2017-12-01
Sarja:American Journal of Ophthalmology Case Reports
Aiheet:
Ziv-aflibercept
Anti-vascular endothelial factor (anti-VEGF)
Macular edema
Central retinal vein occlusion (CRVO)
Optical coherence tomography (OCT)
Linkit:http://www.sciencedirect.com/science/article/pii/S2451993617300336
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia